← Back to results

Mol Ther · 2024

Advancing gene targeting for primary immune deficiencies: Adenine base editing of the human IL2RG locus for correction of SCID-X1.

Molecular therapy : the journal of the American Society of Gene Therapy, 32(6): 1606-1608 PMID 38781958 DOI 10.1016/j.ymthe.2024.05.026

Open in PubMed ↗ Open via DOI ↗

Abstract

This article has no abstract in PubMed.

Cite